Esophagus Cancer Completed Phase 2 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00201747Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach CancerTreatment
NCT00318903Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal CancerTreatment